Skip to content

Multi-disease prevention campaigns (part 2): case studies from Kenya and Uganda

Largest ever number of HIV diagnoses in UK gay men – due to increased testing and new infections

Systematic review and meta-analysis shows equivalence of 3TC and FTC

AbbVie reports 96% cure rate for interferon-free hepatitis C regimen in phase 3 study

Church attendance associated with late HIV diagnosis among US MSM

GAT Portugal

GAT Portugal

Successful hepatitis C treatment reduces risk of liver cancer and death, but most remain untreated

HCV treatment cascade illustration, part of the presentation by Ronald Valdiserri, US Deputy Assistant Secretary for Health, at The Liver Meeting 2013.

Harm reduction works: extremely low HIV incidence over almost 20 years among people who inject drugs in Australia

Sofosbuvir/ribavirin for 24 weeks cures most genotype 3 hepatitis C patients, adding interferon may help difficult-to-treat